COVID-19 Pseudovirus Whole Genome Quality Control Products

Current Status of COVID-19 Pseudovirus Testing

2019 Novel coronavirus (COVID-19) is a single-stranded RNA coronavirus with a genome sequence size of 29903 bp, which is a highly contagious respiratory disease caused by the SARS-CoV-2 virus. COVID-19 is transmitted primarily by respiratory droplets from an infected person who speaks, coughs, or sneezes. Common symptoms include fever, cough and dyspnea. Early diagnosis and timely isolation are the main tools to prevent the spread of new coronaviruses, and nucleic acid testing is the "gold standard" for the diagnosis of COVID-19 virus infection. Quality control is an important step in the production of pseudoviruses to ensure their suitability for research.

CD Genomics offers a wide range of COVID-19 pseudovirus genome-wide quality control products to help you screen, diagnose and monitor COVID-19.

See all Products

COVID-19 Pseudovirus Whole Genome Quality Control Products Details

Our accurate and stable COVID-19 pseudovirus genome-wide quality control products include 2019-nCov virus genome-wide pseudoviruses and can be adapted to the quality control needs of all approved nucleic acid detection kits on the market.

Production Process

Our COVID-19 pseudovirus whole genome quality control product accurately quantifies the copy number of viral genes after extraction by ddPCR, and after lysis, we can obtain a quality control that is accurately quantified as weakly positive.

Product Highlights

The product form is a pseudovirus, which highly simulates real clinical samples.
Covers the whole genome sequence of the virus and is suitable for the approved nucleic acid test kits in the market.
The product can be used for quality control of the entire testing process from the sampling step.
Contains internal reference gene RNase P for internal reference quality control.
The product form of lyophilized beads has better stability, can be transported at room temperature and can be stored stably at 2-8°C for at least 24 months.
Depending on the detection limit of the kit, weakly positive QCs with copy number concentrations in the range of 1.5~3 times the detection limit can be formulated.
Accurate quantification of viral genome copy number by digital PCR after sample extraction.

Applications

Our COVID-19 pseudovirus genome-wide quality control products can be involved in the testing process of each batch of clinical samples to monitor and control the accuracy of laboratory assays.
Our COVID-19 pseudovirus genome-wide quality control products can assist the performance evaluation of new crown testing capabilities at the clinical testing center or at each higher level of the organization.

Product Categories

COVID-19 pseudovirus positive control

* For Research Use Only. Not for use in diagnostic procedures.

Explore Our COVID-19 Pseudovirus Whole Genome Quality Control Products:

Filter by

Cat. No.	Product Name	Brief Description	Inquiry	Basket
CPWGQC001	CD COVID-19 Pseudovirus Whole Genome Quality Control Product	CD COVID-19 Pseudovirus Whole Genome Quality Control Product is a genome-wide pseudovirus quality control product containing 2019-nCov virus, which can be adapted to the quality control needs of all approved nucleic acid test kits in the market.
CPWGQC002	CD COVID-19 Pseudovirus Whole Genome Quality Control II Product	CD COVID-19 Pseudovirus Whole Genome Quality Control II Product is a genome-wide pseudovirus quality control product containing 2019-nCov virus, which can be adapted to the quality control needs of all approved nucleic acid test kits in the market.